跳到主要导航 跳到搜索 跳到主要内容

The discovery of colchicine-SAHA hybrids as a new class of antitumor agents

  • Xuan Zhang
  • , Jie Zhang
  • , Linjiang Tong
  • , Yu Luo
  • , Mingbo Su
  • , Yi Zang
  • , Jia Li
  • , Wei Lu*
  • , Yi Chen
  • *此作品的通讯作者
  • East China Normal University
  • CAS - Shanghai Institute of Materia Medica

科研成果: 期刊稿件文章同行评审

摘要

A novel class of colchicine-SAHA hybrids were designed and synthesised based on the synergistic antitumor effect of tubulin inhibitors and histone deacetylases (HDAC) inhibitors. To the best of our knowledge, this is the first design of molecules that are dual inhibitors of tubulin and HDAC. Biological evaluations of these compounds included the inhibitory activity of HDAC, in vitro cell cycle analysis in BEL-7402 cells as well as cytotoxicity in five cancer cell lines.

源语言英语
页(从-至)3240-3244
页数5
期刊Bioorganic and Medicinal Chemistry
21
11
DOI
出版状态已出版 - 1 6月 2013

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

指纹

探究 'The discovery of colchicine-SAHA hybrids as a new class of antitumor agents' 的科研主题。它们共同构成独一无二的指纹。

引用此